Good evening,
Wow, TTNP is really cranking up. Should held those shares at 70 cents few months back. Fanapt will be a big money maker just like all the other atypical antipsychotics. Without looking at R&D and S&G expenses, Fanapt could be bringing in $100mil and $50-75mil to the top and bottom line respectively. That's simply huge. I knew it was going to be big eventually, but I did not have ready funds to buy big at the time. Hang onto your shares because 8-10% royalty on top line is almost unheard of these days.
Re: ILNS
I been buying some shares here and there. Bought some today at 12 and 13 cents. With public float of 19mil and effective float much less, I figured only way to buy some is to hit the ask before it goes up much more. Thanks to your alert, I have been doing a lot of research into Alzheimers' drug development and Intellect Neuroscience specifically. If all works out even a half way, Bapineuzumab will be one of its kind in treating Alzheimers' disease. All the current drug therapies, Aricept, Namenda, and Exelon, treat symptoms. Bap will be the first disease modifying drug to treat alzheimers' disease. Found out big companies, Pfizer (own 50% of Bap through acquisition of Wye), Elan (25%) and JNJ (25%) are allocating big resources to bring this drug to market. Pfizer and JNJ know how to market a drug and make it a blockbuster. Once it's approved I am certain Bap sales will be in the billions$.
Re: PWRN
I haven't looked at it yet. Maybe I will start doing some research since it is getting close to your buying zone.
BTW, what got your interest in PWRM?
Good to hear you're doing well.
News 
Market Data 
Discover 
